Miotic Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
- Paid Up Capital ₹ 0.30 M
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 1.87%
- Profit Growth 16.79%
- Ebitda 42.40%
- Net Worth 73.30%
- Total Assets 20.76%
About Miotic Pharmaceutical
Miotic Pharmaceutical Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 June 2020 (Four years and seven months 10 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Anita Barlota, Bheekaram Devasi, and Mishri Lal serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24296MH2020PTC341212
-
Company No.
341212
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Jun 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Miotic Pharmaceutical?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anita Barlota
|
Director | 30-Jun-2020 | Current |
|
Bheekaram Devasi
|
Director | 30-Jun-2020 | Current |
|
Mishri Lal
|
Director | 30-Jun-2020 | Current |
Financial Performance of Miotic Pharmaceutical.
Miotic Pharmaceutical Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.87% increase. The company also saw a substantial improvement in profitability, with a 16.79% increase in profit. The company's net worth Soared by an impressive increase of 73.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Miotic Pharmaceutical?
Unlock access to Miotic Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Omsterling LlpAnita Barlota is a mutual person
-
Magnova Pharmaceutical Private Limited
Mishri Lal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Miotic Pharmaceutical?
Miotic Pharmaceutical has a workforce of 13 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Miotic Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Miotic Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.